0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Handbook of Biogeneric Therapeutic Proteins - Regulatory, Manufacturing, Testing, and Patent Issues (Paperback) Loot Price: R1,801
Discovery Miles 18 010
Handbook of Biogeneric Therapeutic Proteins - Regulatory, Manufacturing, Testing, and Patent Issues (Paperback): Sarfaraz K....

Handbook of Biogeneric Therapeutic Proteins - Regulatory, Manufacturing, Testing, and Patent Issues (Paperback)

Sarfaraz K. Niazi

 (sign in to rate)
Loot Price R1,801 Discovery Miles 18 010 | Repayment Terms: R169 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

More than 20 billion dollars worth of biopharmaceuticals are scheduled to go off-patent by 2006. Given the strong political impetus and the development of technological tools that can answer the questions regulatory authorities may raise, it is inevitable that the FDA and EMEA will allow biogeneric or biosimilar products. Even with all the regulatory wrinkles yet to be ironed out, generic or similar biological products are soon to become a reality. Handbook of Biogeneric Therapeutic Proteins is the first book to review and analyze the status of biotechnology, regulatory environment, manufacturing methodologies, testing requirements and intellectual property issues. The book provides complete and thorough coverage of the regulatory and technological challenges of developing generic therapeutic proteins and how to prepare detailed regulatory and manufacturing plans and policies. The author includes information on establishing a manufacturing system, securing regulatory approval, and setting up facilities to manufacture raw materials and prepare finished products. He also supplies details about the Chemistry, Manufacturing, and Controls (CMC) section of the FDA's New Drug Application for Biological Products. In brief, the book supplies everything a manufacturer would need to plan the development of biogeneric products and complete the process of regulatory filing. Waiting for the FDA to issue guidelines is a mistake. The scramble to catch up could leave your company way behind in the game. Your organization needs to begin developing and characterizing genetically modified cells now and to complete initial GMP production runs through a CRO to get ready for the newer testing the FDA might impose. Packed with tables and figures that provide speedy access to precise, timely data, including full formulation details on all FDA approved biological product, this book contains a broad range of resource materials about suppliers, manufacturers, and testing faciliti

General

Imprint: Crc Press
Country of origin: United Kingdom
Release date: December 2019
First published: 2006
Authors: Sarfaraz K. Niazi
Dimensions: 254 x 178mm (L x W)
Format: Paperback
Pages: 584
ISBN-13: 978-0-367-45481-4
Categories: Books > Science & Mathematics > Biology, life sciences > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 0-367-45481-5
Barcode: 9780367454814

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners